Correlation Between Mineralys Therapeutics, and Xencor

Can any of the company-specific risk be diversified away by investing in both Mineralys Therapeutics, and Xencor at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mineralys Therapeutics, and Xencor into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Mineralys Therapeutics, Common and Xencor Inc, you can compare the effects of market volatilities on Mineralys Therapeutics, and Xencor and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mineralys Therapeutics, with a short position of Xencor. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mineralys Therapeutics, and Xencor.

Diversification Opportunities for Mineralys Therapeutics, and Xencor

-0.04

Correlation Coefficient

Mineralys Therapeutics,  Xencor

Good diversification

The 3 months correlation between Mineralys and Xencor is -0.04. Overlapping area represents the amount of risk that can be diversified away by holding Mineralys Therapeutics, Common and Xencor Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Xencor Inc and Mineralys Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mineralys Therapeutics, Common are associated (or correlated) with Xencor. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Xencor Inc has no effect on the direction of Mineralys Therapeutics, i.e., Mineralys Therapeutics, and Xencor go up and down completely randomly.

Pair Corralation between Mineralys Therapeutics, and Xencor

Given the investment horizon of 90 days Mineralys Therapeutics, Common is expected to generate 2.58 times more return on investment than Xencor. However, Mineralys Therapeutics, is 2.58 times more volatile than Xencor Inc. It trades about 0.11 of its potential returns per unit of risk. Xencor Inc is currently generating about -0.34 per unit of risk. If you would invest  1,206  in Mineralys Therapeutics, Common on December 23, 2024 and sell it today you would earn a total of  481.00  from holding Mineralys Therapeutics, Common or generate 39.88% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Mineralys Therapeutics, Common  vs.  Xencor Inc

Mineralys Therapeutics,

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Mineralys Therapeutics, Common are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively inconsistent basic indicators, Mineralys Therapeutics, unveiled solid returns over the last few months and may actually be approaching a breakup point.

Xencor Inc

Risk-Adjusted Performance

Very Weak

Over the last 90 days Xencor Inc has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's fundamental indicators remain relatively invariable which may send shares a bit higher in April 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Pair Trading with Mineralys Therapeutics, and Xencor

The main advantage of trading using opposite Mineralys Therapeutics, and Xencor positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mineralys Therapeutics, position performs unexpectedly, Xencor can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Xencor will offset losses from the drop in Xencor's long position.

The idea behind Mineralys Therapeutics, Common and Xencor Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.